E N D
Supplementary Figure 5. Changes in sarcoglycan expression do not correlate with genetic cause or disease severity in known forms of muscular dystrophy. Western blot analysis of - and -sarcoglycan expression in 2 Duchenne muscular dystrophy (DMD) patients (lanes 2, 3), 2 dysferlinopathy patients (Dysf; lanes 5, 6) and 2 caveolinopathy patients (Cav; lanes 8, 9) demonstrates variable levels of the sarcoglycans without a clear relationship with diagnosis or disease severity. Lanes 1, 4, 7 & 10 are age-matched controls (C). Right panel shows standard curves for each protein (Std Curve).